Corporate GovernanceMay 5, 2026, 07:28 AM
FibroBiologics Grants Stock Options to Key Executives
AI Summary
FibroBiologics, Inc. granted stock options to its Chief Executive Officer, Chief Financial Officer, Chief Scientific Officer, and General Counsel on May 4, 2026. CEO Pete O R Heeron received options for 92,410 shares, while Jason D. Davis (CFO), Hamid Khoja (CSO), and Ruben A. Garcia (General Counsel) each received options for 61,607 shares. The options are exercisable at $1.38 per share and vest over four years, with the first quarter vesting on the one-year anniversary and the rest monthly thereafter.
Key Highlights
- CEO Pete O R Heeron granted options to purchase 92,410 shares of common stock.
- CFO Jason D. Davis granted options to purchase 61,607 shares of common stock.
- CSO Hamid Khoja granted options to purchase 61,607 shares of common stock.
- General Counsel Ruben A. Garcia granted options to purchase 61,607 shares of common stock.
- All options are exercisable at an exercise price of $1.38 per share.
- Options vest 1/4th on the one-year anniversary, with the remainder vesting in 36 equal monthly installments.
Price Impact
More from FBLG